HL7 Terminology (THO)
4.0.0 - Publication International flag

This page is part of the HL7 Terminology (v4.0.0: Release) based on FHIR R4. The current version which supercedes this version is 5.2.0. For a full list of available versions, see the Directory of published versions

ValueSet: SubstanceAdminSubstitutionNotAllowedReason

Official URL: http://terminology.hl7.org/ValueSet/v3-SubstanceAdminSubstitutionNotAllowedReason Version: 2.0.0
Active as of 2014-03-26 Computable Name: SubstanceAdminSubstitutionNotAllowedReason
Other Identifiers: : urn:oid:2.16.840.1.113883.1.11.19719

Reasons why substitution of a substance administration request is not permitted.

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

This value set includes codes based on the following rules:

 

Expansion

This value set contains 5 concepts

Expansion based on ActReason v2.1.0 (CodeSystem)

CodeSystemDisplayDefinition
  PAThttp://terminology.hl7.org/CodeSystem/v3-ActReasonPatient request

The Patient requested the action

  _SubstanceAdminSubstitutionNotAllowedReasonhttp://terminology.hl7.org/CodeSystem/v3-ActReasonSubstanceAdminSubstitutionNotAllowedReason

Reasons why substitution of a substance administration request is not permitted.

  ALGINThttp://terminology.hl7.org/CodeSystem/v3-ActReasonallergy intolerance

Definition: Patient has had a prior allergic intolerance response to alternate product or one of its components.

  COMPCONhttp://terminology.hl7.org/CodeSystem/v3-ActReasoncompliance concern

Definition: Patient has compliance issues with medication such as differing appearance, flavor, size, shape or consistency.

  THERCHARhttp://terminology.hl7.org/CodeSystem/v3-ActReasontherapeutic characteristics

The prescribed product has specific clinical release or other therapeutic characteristics not shared by other substitutable medications.

  TRIALhttp://terminology.hl7.org/CodeSystem/v3-ActReasonclinical trial drug

Definition: The specific manufactured drug is part of a clinical trial.

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code

History

DateActionCustodianAuthorComment
2020-05-06reviseVocabulary WGTed KleinMigrated to the UTG maintenance environment and publishing tooling.
2014-03-26revise2014T1_2014-03-26_001283 (RIM release ID)Vocabulary (Woody Beeler) (no record of original request)Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26